Cargando…

Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission

OBJECTIVES: Limosilactobacillus reuteri FN041 is a potential probiotic bacterium isolated from breast milk in traditional farming and pastoral areas of China. The purpose of this study was to investigate the optimal intervention mode and potential mechanism of FN041 to prevent atopic dermatitis (AD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jingbo, Xu, Gaoshun, Li, Xinyue, Tu, Huayu, Li, Haoyu, Chang, Hong, Chen, Jie, Yu, Renqiang, Qi, Ce, Sun, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554658/
https://www.ncbi.nlm.nih.gov/pubmed/36245510
http://dx.doi.org/10.3389/fnut.2022.987400
_version_ 1784806749109223424
author Zhou, Jingbo
Xu, Gaoshun
Li, Xinyue
Tu, Huayu
Li, Haoyu
Chang, Hong
Chen, Jie
Yu, Renqiang
Qi, Ce
Sun, Jin
author_facet Zhou, Jingbo
Xu, Gaoshun
Li, Xinyue
Tu, Huayu
Li, Haoyu
Chang, Hong
Chen, Jie
Yu, Renqiang
Qi, Ce
Sun, Jin
author_sort Zhou, Jingbo
collection PubMed
description OBJECTIVES: Limosilactobacillus reuteri FN041 is a potential probiotic bacterium isolated from breast milk in traditional farming and pastoral areas of China. The purpose of this study was to investigate the optimal intervention mode and potential mechanism of FN041 to prevent atopic dermatitis (AD) in mice. METHODS: In intervention mode I, FN041 was supplemented to dams during the late trimester and lactation and pups after weaning; in intervention mode II, FN041 was supplemented after pups were weaned. AD was induced in pups with MC903 plus ovalbumin on the ear after weaning. RESULTS: The effect of intervention mode I in preventing AD was significantly better than that of intervention mode II. Compared with the model group, the inflammatory response of the pup’s ears, the proportion of spleen regulatory T cells and the plasma IgE were significantly decreased in mice in intervention mode I. Furthermore, the intestinal mucosal barrier was enhanced, and the Shannon index of the ileal microbiota was significantly increased. The microbiota structure deviated from the AD controls and shifted toward the healthy controls according to the PCoA of unweighted UniFrac. The relative abundances of Limosilactobacillus, Faecalibacterium, Bifidobacterium, and Akkermansia in the ileum were significantly increased compared to the AD group. Based on RNA-seq analysis of pups’ Peyer’s patches (PPs), FN041 inhibits autoimmune pathways such as asthma and systemic lupus erythematosus and activates retinol metabolism and PPAR signaling pathways to reduce inflammatory responses. Intervention mode II also significantly reduced AD severity score, but the reduction was approximately 67% of that of intervention mode I. This may be related to its ineffective remodeling of the ileal microbiota. CONCLUSION: Prenatal and postnatal administration of FN041 is an effective way to prevent AD in offspring, and its mechanism is related to remodeling of ileal microbiota and PPs immune response.
format Online
Article
Text
id pubmed-9554658
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95546582022-10-13 Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission Zhou, Jingbo Xu, Gaoshun Li, Xinyue Tu, Huayu Li, Haoyu Chang, Hong Chen, Jie Yu, Renqiang Qi, Ce Sun, Jin Front Nutr Nutrition OBJECTIVES: Limosilactobacillus reuteri FN041 is a potential probiotic bacterium isolated from breast milk in traditional farming and pastoral areas of China. The purpose of this study was to investigate the optimal intervention mode and potential mechanism of FN041 to prevent atopic dermatitis (AD) in mice. METHODS: In intervention mode I, FN041 was supplemented to dams during the late trimester and lactation and pups after weaning; in intervention mode II, FN041 was supplemented after pups were weaned. AD was induced in pups with MC903 plus ovalbumin on the ear after weaning. RESULTS: The effect of intervention mode I in preventing AD was significantly better than that of intervention mode II. Compared with the model group, the inflammatory response of the pup’s ears, the proportion of spleen regulatory T cells and the plasma IgE were significantly decreased in mice in intervention mode I. Furthermore, the intestinal mucosal barrier was enhanced, and the Shannon index of the ileal microbiota was significantly increased. The microbiota structure deviated from the AD controls and shifted toward the healthy controls according to the PCoA of unweighted UniFrac. The relative abundances of Limosilactobacillus, Faecalibacterium, Bifidobacterium, and Akkermansia in the ileum were significantly increased compared to the AD group. Based on RNA-seq analysis of pups’ Peyer’s patches (PPs), FN041 inhibits autoimmune pathways such as asthma and systemic lupus erythematosus and activates retinol metabolism and PPAR signaling pathways to reduce inflammatory responses. Intervention mode II also significantly reduced AD severity score, but the reduction was approximately 67% of that of intervention mode I. This may be related to its ineffective remodeling of the ileal microbiota. CONCLUSION: Prenatal and postnatal administration of FN041 is an effective way to prevent AD in offspring, and its mechanism is related to remodeling of ileal microbiota and PPs immune response. Frontiers Media S.A. 2022-09-28 /pmc/articles/PMC9554658/ /pubmed/36245510 http://dx.doi.org/10.3389/fnut.2022.987400 Text en Copyright © 2022 Zhou, Xu, Li, Tu, Li, Chang, Chen, Yu, Qi and Sun. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nutrition
Zhou, Jingbo
Xu, Gaoshun
Li, Xinyue
Tu, Huayu
Li, Haoyu
Chang, Hong
Chen, Jie
Yu, Renqiang
Qi, Ce
Sun, Jin
Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission
title Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission
title_full Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission
title_fullStr Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission
title_full_unstemmed Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission
title_short Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission
title_sort limosilactobacillus reuteri fn041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in peyer’s patches after vertical transmission
topic Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554658/
https://www.ncbi.nlm.nih.gov/pubmed/36245510
http://dx.doi.org/10.3389/fnut.2022.987400
work_keys_str_mv AT zhoujingbo limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission
AT xugaoshun limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission
AT lixinyue limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission
AT tuhuayu limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission
AT lihaoyu limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission
AT changhong limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission
AT chenjie limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission
AT yurenqiang limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission
AT qice limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission
AT sunjin limosilactobacillusreuterifn041preventsatopicdermatitisinpupmicebyremodelingtheilealmicrobiotaandregulatinggeneexpressioninpeyerspatchesafterverticaltransmission